Compare NOK & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NOK | NTRA |
|---|---|---|
| Founded | 1865 | 2003 |
| Country | Finland | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.7B | 56.7B |
| IPO Year | 1994 | 2015 |
| Metric | NOK | NTRA |
|---|---|---|
| Price | $6.90 | $274.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 23 |
| Target Price | $14.52 | ★ $412.36 |
| AVG Volume (30 Days) | ★ 60.1M | 2.0M |
| Earning Date | 10-22-2026 | 11-05-2026 |
| Dividend Yield | ★ 1.45% | N/A |
| EPS Growth | N/A | ★ 0.65 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $210,939,000.00 |
| Revenue This Year | $4.40 | $30.72 |
| Revenue Next Year | $8.31 | $21.67 |
| P/E Ratio | $55.51 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.91 | $181.00 |
| 52 Week High | $17.45 | $437.41 |
| Indicator | NOK | NTRA |
|---|---|---|
| Relative Strength Index (RSI) | 30.04 | 24.66 |
| Support Level | $6.88 | $254.83 |
| Resistance Level | $10.99 | $288.04 |
| Average True Range (ATR) | 0.32 | 19.03 |
| MACD | -0.05 | -7.70 |
| Stochastic Oscillator | 3.25 | 1.47 |
Nokia is a networking equipment vendor focused primarily on supporting wireless networks and, to a growing extent, Internet Protocol and optical systems. The firm operates three segments. The mobile infrastructure segment sells equipment and software used to operate the core of carrier and enterprise wireless networks. Network infrastructure comprises IP, optical, and fixed-network equipment, including switching and routing equipment, optical components, and devices used in fiber-to-the-premises networks. The portfolio business comprises businesses considered noncore to Nokia in the future, including fixed wireless access customer premises equipment, enterprise campus edge, and microwave radio.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.